Hypocretin modulation of drug-induced synaptic plasticity

Progress in Brain Research

Volumn 198, Issue , 2012, Pages 123-131

  Baimel, Corey ^a   Borgland, Stephanie L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Dopamine; Hypocretin; Motivation; NMDA receptor; Orexin; Plasticity; VTA

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OREXIN A; OREXIN B;

ARTICLE; BEHAVIOR; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTUM;

EID: 84863867283     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59489-1.00008-2     Document Type: Chapter

References (57)

1. Adamantidis A.R., Zhang F., Aravanis A.M., Deisseroth K., De Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 2007, 450(7168):420-424.
2. Akanmu M.A., Honda K. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats. Brain Research 2005, 1048(1-2):138-145.
3. Alberto C.O., Trask R.B., Quinlan M.E., Hirasawa M. Bidirectional dopaminergic modulation of excitatory synaptic transmission in orexin neurons. The Journal of Neuroscience 2006, 26(39):10043-10050.
4. Argilli E., Sibley D.R., Malenka R.C., England P.M., Bonci A. Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. The Journal of Neuroscience 2008, 28(37):9092-9100.
5. Balcita-Pedicino J.J., Sesack S.R. Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and gamma-aminobutyric acid neurons. The Journal of Comparative Neurology 2007, 503(5):668-684.
6. Baldo B.A., Daniel R.A., Berridge C.W., Kelley A.E. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. The Journal of Comparative Neurology 2003, 464(2):220-237.
7. Bonci A., Malenka R.C. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. The Journal of Neuroscience 1999, 19(10):3723-3730.
8. Borgland S.L., Chang S.J., Bowers M.S., Thompson J.L., Vittoz N., Floresco S.B., et al. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. The Journal of Neuroscience 2009, 29(36):11215-11225.
9. Borgland S.L., Malenka R.C., Bonci A. Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: Electrophysiological and behavioral correlates in individual rats. The Journal of Neuroscience 2004, 24(34):7482-7490.
10. Borgland S.L., Storm E., Bonci A. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons. The European Journal of Neuroscience 2008, 28(8):1545-1556.
11. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49(4):589-601.
12. Bubser M., Fadel J.R., Jackson L.L., Meador-Woodruff J.H., Jing D., Deutch A.Y. Dopaminergic regulation of orexin neurons. The European Journal of Neuroscience 2005, 21(11):2993-3001.
13. Carter M.E., Adamantidis A., Ohtsu H., Deisseroth K., De Lecea L. Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions. The Journal of Neuroscience 2009, 29(35):10939-10949.
14. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., et al. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 1999, 98(4):437-451.
15. Colussi-Mas J., Geisler S., Zimmer L., Zahm D.S., Berod A. Activation of afferents to the ventral tegmental area in response to acute amphetamine: A double-labelling study. The European Journal of Neuroscience 2007, 26(4):1011-1025.
16. De Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(1):322-327.
17. España R.A., Melchior J.R., Roberts D.C., Jones S.R. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology 2011, 214:415-426.
18. España R.A., Oleson E.B., Locke J.L., Brookshire B.R., Roberts D.C., Jones S.R. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. The European Journal of Neuroscience 2010, 31:336-348.
19. Fadel J., Deutch A.Y. Anatomical substrates of orexin-dopamine interactions: Lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002, 111(2):379-387.
20. Georgescu D., Zachariou V., Barrot M., Mieda M., Willie J.T., Eisch A.J., et al. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. The Journal of Neuroscience 2003, 23(8):3106-3111.
21. Huang H., Acuna-Goycolea C., Li Y., Cheng H.M., Obrietan K., Van Den Pol A.N. Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: Implications for cannabinoid actions on food intake and cognitive arousal. The Journal of Neuroscience 2007, 27(18):4870-4881.
22. Kalivas P.W., Alesdatter J.E. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. The Journal of Pharmacology and Experimental Therapeutics 1993, 267(1):486-495.
23. Korotkova T.M., Sergeeva O.A., Eriksson K.S., Haas H.L., Brown R.E. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. The Journal of Neuroscience 2003, 23(1):7-11.
24. Li Y., Van Den Pol A.N. Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. The Journal of Neuroscience 2005, 25(1):173-183.
25. Li Y., Van Den Pol A.N. Mu-opioid receptor-mediated depression of the hypothalamic hypocretin/orexin arousal system. The Journal of Neuroscience 2008, 28(11):2814-2819.
26. Moorman D.E., Aston-Jones G. Orexin/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: Diurnal influences. The Journal of Neuroscience 2010, 30(46):15585-15599.
27. Morshedi M.M., Meredith G.E. Repeated amphetamine administration induces Fos in prefrontal cortical neurons that project to the lateral hypothalamus but not the nucleus accumbens or basolateral amygdala. Psychopharmacology 2008, 197(2):179-189.
28. Murase S., Grenhoff J., Chouvet G., Gonon F.G., Svensson T.H. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neuroscience Letters 1993, 157(1):53-56.
29. Muschamp J.W., Dominguez J.M., Sato S.M., Shen R.Y., Hull E.M. A role for hypocretin (orexin) in male sexual behavior. The Journal of Neuroscience 2007, 27(11):2837-2845.
30. Narita M., Nagumo Y., Hashimoto S., Khotib J., Miyatake M., Sakurai T., et al. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. The Journal of Neuroscience 2006, 26(2):398-405.
31. Narita M., Nagumo Y., Miyatake M., Ikegami D., Kurahashi K., Suzuki T. Implication of protein kinase C in the orexin-induced elevation of extracellular dopamine levels and its rewarding effect. The European Journal of Neuroscience 2007, 25(5):1537-1545.
32. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 2004, 47:24-32.
33. Overton P., Clark D. Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons. Synapse 1992, 10(2):131-140.
34. Overton P.G., Richards C.D., Berry M.S., Clark D. Long-term potentiation at excitatory amino acid synapses on midbrain dopamine neurons. Neuroreport 1999, 10(2):221-226.
35. Peyron C., Tighe D.K., Van Den Pol A.N., De Lecea L., Heller H.C., Sutcliffe J.G., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. The Journal of Neuroscience 1998, 18(23):9996-10015.
36. Phillipson O.T. Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: A horseradish peroxidase study in the rat. The Journal of Comparative Neurology 1979, 187(1):117-143.
37. Quarta D., Valerio E., Hutcheson D.M., Hedou G., Heidbreder C. The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization. Neurochemistry International 2009, 56(1):11-15.
38. Rao Y., Liu Z.W., Borok E., Rabenstein R.L., Shanabrough M., Lu M., et al. Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neurons. The Journal of Clinical Investigation 2007, 117(12):4022-4033.
39. Richardson N.R., Roberts D.C. Progressive ratio schedules in drug self-administration studies in rats: A method to evaluate reinforcing efficacy. Journal of Neuroscience Methods 1996, 66(1):1-11.
40. Robinson T.E., Berridge K.C. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research. Brain Research Reviews 1993, 18(3):247-291.
41. Robinson T.E., Berridge K.C. Incentive-sensitization and addiction. Addiction 2001, 96(1):103-114.
42. Rosin D.L., Weston M.C., Sevigny C.P., Stornetta R.L., Guyenet P.G. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. The Journal of Comparative Neurology 2003, 465(4):593-603.
43. Saal D., Dong Y., Bonci A., Malenka R.C. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 2003, 37(4):577-582.
44. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92(4):573-585.
45. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. The Journal of Comparative Neurology 1989, 290(2):213-242.
46. Sesack S.R., Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. The Journal of Comparative Neurology 1992, 320(2):145-160.
47. Sharf R., Guarnieri D.J., Taylor J.R., Dileone R.J. Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization. Brain Research 2010, 1317:24-32.
48. Suaud-Chagny M.F., Chergui K., Chouvet G., Gonon F. Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience 1992, 49(1):63-72.
49. Thompson J.L., Borgland S.L. A role for hypocretin/orexin in motivation. Behavioural Brain Research 2010, 217(2):446-453.
50. Tong Z.Y., Overton P.G., Clark D. Antagonism of NMDA receptors but not AMPA/kainate receptors blocks bursting in dopaminergic neurons induced by electrical stimulation of the prefrontal cortex. Journal of Neural Transmission 1996, 103(8-9):889-904.
51. Ungless M.A., Whistler J.L., Malenka R.C., Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 2001, 411(6837):583-587.
52. Uramura K., Funahashi H., Muroya S., Shioda S., Takigawa M., Yada T. Orexin-a activates phospholipase C- and protein kinase C-mediated Ca2+ signaling in dopamine neurons of the ventral tegmental area. Neuroreport 2001, 12(9):1885-1889.
53. Vittoz N.M., Berridge C.W. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: Involvement of the ventral tegmental area. Neuropsychopharmacology 2006, 31(2):384-395.
54. Vittoz N.M., Schmeichel B., Berridge C.W. Hypocretin/orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. The European Journal of Neuroscience 2008, 28(8):1629-1640.
55. Yoshida K., Mccormack S., Espana R.A., Crocker A., Scammell T.E. Afferents to the orexin neurons of the rat brain. The Journal of Comparative Neurology 2006, 494(5):845-861.
56. Zhu Y., Miwa Y., Yamanaka A., Yada T., Shibahara M., Abe Y., et al. Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and -insensitive G-proteins. Journal of Pharmacological Sciences 2003, 92(3):259-266.
57. Ziegler D.R., Cullinan W.E., Herman J.P. Distribution of vesicular glutamate transporter mRNA in rat hypothalamus. The Journal of Comparative Neurology 2002, 448(3):217-229.